Skip to main content

Monoclonal antibody drugs to treat COVID-19 infections are no longer available in Minnesota, health officials have confirmed. 

The U.S. Food and Drug Administration on Wednesday announced it had ended emergency use authorization for Eli Lilly's monoclonal antibody treatment for COVID-19, Bebtelovimab, in light of the rising BQ.1 and BQ.1.1 variants.

The decision comes amid data that the drug is not expected to be effective at treating the latest COVID-19 variants circulating across the country, according to the FDA. 

The latest COVID-19 wastewater data from the Metropolitan Council indicates the BQ.1 strain is now dominate in the Twin Cities and beginning to surge, with the variant accounting for about 58% of the COVID-19 viral particles entering the wastewater plant. 

Bebtelovimab had previously been given emergency use authorization for the treatment of mild-to-moderate COVID-19 in certain pediatric and adult patients at higher risk of severe illness or death from the virus. 

Two monoclonal antibody treatments — Bamlanivimab and Etesevimab — lost authorization in January amid the Omicron surge. Another monoclonal antibody drug — Sotrovimab — lost authorization in March.

"As of now, there are no monoclonal antibodies for treatment of acute infection that are authorized for use anywhere in the U.S.," Garry Bowman, spokesperson for the Minnesota Department of Health, confirmed Friday. "So this is not just an issue here in Minnesota." 

This week's announcement from the FDA regarding Bebtelovimab, which was the last monoclonal antibody treatment still authorized for COVID-19 in the U.S., has increased fears among many physicians and high-risk patients about the winter ahead. 

According to Bowman, at least 11,362 courses of Bebtelovimab were given to patients in Minnesota since its authorization earlier this year. 

However, the actual number is likely much higher as Bowman said not all providers report their usage and the state only tracks products in the government's supply — not drugs purchased commercially. 

Paxlovid, Veklury, Lagevrio and convalescent plasma treatments remain authorized for the treatment of COVID-19 in eligible patients in the U.S., according to the FDA.

Bowman said Minnesotans at higher risk of developing severe illness should contact their healthcare provider if they test positive for COVID-19 to learn what might be right for them. 

"Oral antivirals are effective against all of the current circulating variants and are still authorized and recommended for use," he said. 

Evusheld, another defense for immunocompromised Americans, is also still available in Minnesota. 

The monoclonal antibody therapy doesn't treat COVID-19, but it's rather used as a pre-exposure prophylaxis to help certain high-risk patients avoid catching the virus in the first place. 

However, many experts believe Evusheld is also on shaky ground and quickly headed towards the same fate as Bebtelovimab. 

While Evusheld remains available in U.S. for now, the FDA last month warned some emerging variants were not neutralized by the therapy. 

Next Up


Two youths seriously injured after being struck by driver in Bloomington

Police say the boy is in a critical condition, while the girl has severe injuries.

Rosedale Center

Two men sentenced for carjacking in Rosedale Center parking lot

Leon Kismit Bell, 49, and Jack Mitchell Piche, 23, were sentenced in U.S. District Court on Jan. 20.

Screen Shot 2023-01-27 at 3.59.30 PM

Police identify White Bear Lake officer shot while serving warrant

The officer is a six-year veteran of the department.

abortion, planned parenthood

Minnesota Senate passes bill codifying abortion into state law

Having already passed in the House, it will now be sent to Gov. Tim Walz for signing into law.

Screen Shot 2023-01-27 at 7.45.44 PM

Tyre Nichols: Initial police version of events bear similarities to George Floyd killing

Memphis PD said Nichols complained of 'shortness of breath' following 'confrontations' with police, who in reality violently beat him.

George Floyd, protest

Twin Cities authorities preparing for community reaction to Tyre Nichols video

The ATF division in St. Paul sent out an alert out of "an abundance of caution."

Screen Shot 2023-01-27 at 2.12.05 PM

Changes at K102's Chris Carr & Company, with Sam Sansevere joining as co-host

She is the daughter of former KQRS morning show personality Bob Sansevere.

Screen Shot 2023-01-27 at 1.16.21 PM

Minneapolis' Royal Foundry Craft Spirits announces closure

The distillery set out to infuse the Minneapolis craft cocktail scene with British flavor.


Shutterfly to cut almost 100 jobs at Shakopee facility

The layoffs are expected to impact multiple positions within the company.


flickr jernej furman covid home test

Minnesota launches telehealth program to offer no-cost COVID-19 therapeutics

The new telehealth program offers no-cost virtual care and therapeutics for COVID-19.


Walz responds to Osterholm's prediction of a variant-driven spike

Osterholm remains confident that the B.1.1.7. variant will cause big problems within 14 weeks.

Pixabay - doctor close-up stock

Minnesota opens COVID antibody treatment clinic in the Twin Cities

The treatment can decrease the likelihood someone will need to be hospitalized.

Monoclonal antibodies

COVID: New monoclonal antibody clinic to open in Twin Cities

Monoclonal antibody treatment can help prevent hospitalization from COVID.


Minnesota's COVID-19 update for Friday, January 7

The latest about Minnesota's COVID-19 surge.


First omicron variant COVID case detected in MN

The individual is an adult male who lives in Hennepin County and had recently traveled.


How the Delta variant is affecting Minnesota's COVID-19 status

The number of cases identified as the Delta variant are rising.